In vitro and in vivo characterisation of [3H]ANSTO-14 binding to the σ1 binding sites
- 28 February 1999
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 26 (2) , 209-215
- https://doi.org/10.1016/s0969-8051(98)00095-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor bindingNuclear Medicine and Biology, 1996
- Trishomocubanes, a new class of selective and high affinity ligands for the sigma binding siteBioorganic & Medicinal Chemistry Letters, 1996
- Sigma receptors are expressed in human non-small cell lung carcinomaLife Sciences, 1995
- Conformational Analysis, Pharmacophore Identification, and Comparative Molecular Field Analysis of Ligands for the Neuromodulatory .sigma.3 ReceptorJournal of Medicinal Chemistry, 1994
- Allosteric modulation of ligand binding to [3H](+)pentazocine-defined σ recognition sites by phenytoinLife Sciences, 1993
- Calculating receptor number from binding experiments using same compound as radioligand and competitorTrends in Pharmacological Sciences, 1989
- Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1- propyl)piperidineJournal of Neuroscience, 1986
- A practical computer-based approach to the analysis of radioligand binding experimentsComputer Programs in Biomedicine, 1983
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973